NO992186D0 - System med forsinket avlevering for syresensitive medikamenter - Google Patents
System med forsinket avlevering for syresensitive medikamenterInfo
- Publication number
- NO992186D0 NO992186D0 NO992186A NO992186A NO992186D0 NO 992186 D0 NO992186 D0 NO 992186D0 NO 992186 A NO992186 A NO 992186A NO 992186 A NO992186 A NO 992186A NO 992186 D0 NO992186 D0 NO 992186D0
- Authority
- NO
- Norway
- Prior art keywords
- delivery system
- acid
- barrier
- omeprazole
- pulsatile
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74098196A | 1996-11-06 | 1996-11-06 | |
PCT/US1997/020851 WO1998019668A1 (en) | 1996-11-06 | 1997-11-05 | Delayed delivery system for acid-sensitive drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
NO992186L NO992186L (no) | 1999-05-05 |
NO992186D0 true NO992186D0 (no) | 1999-05-05 |
Family
ID=24978866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO992186A NO992186D0 (no) | 1996-11-06 | 1999-05-05 | System med forsinket avlevering for syresensitive medikamenter |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0941074B1 (de) |
AT (1) | ATE271379T1 (de) |
AU (1) | AU5179898A (de) |
DE (1) | DE69729950T2 (de) |
NO (1) | NO992186D0 (de) |
WO (1) | WO1998019668A1 (de) |
ZA (1) | ZA979937B (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2774288B1 (fr) | 1998-01-30 | 2001-09-07 | Ethypharm Sa | Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques |
FR2793688B1 (fr) | 1999-05-21 | 2003-06-13 | Ethypharm Lab Prod Ethiques | Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques |
SE9902386D0 (sv) * | 1999-06-22 | 1999-06-22 | Astra Ab | New formulation |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
DE19959419A1 (de) | 1999-12-09 | 2001-06-21 | Ratiopharm Gmbh | Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung |
ATE297194T1 (de) * | 1999-12-16 | 2005-06-15 | Medinfar Produtos Farmaceutico | Neue stabile mehreinheitliche substituierte benzimidazole enthaltende pharmazeutische präparate |
US6500457B1 (en) * | 2000-08-14 | 2002-12-31 | Peirce Management, Llc | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
JP4551089B2 (ja) * | 2001-10-29 | 2010-09-22 | マサチューセッツ インスティテュート オブ テクノロジー | 三次元印刷により製造されたゼロ次放出プロフィール投薬形態のような徐放投薬形態を製造するためのシステム |
US8168170B2 (en) | 2002-10-03 | 2012-05-01 | The Procter And Gamble Company | Compositions having an inner core and at least three surrounding layers |
EP1602362B1 (de) * | 2003-03-12 | 2016-09-28 | Takeda Pharmaceutical Company Limited | Arzneimittelzusammensetzung mit wirkstoff, der in hoher konzentration an einem kugelförmigen kern anhaftet |
WO2005051362A2 (en) * | 2003-11-28 | 2005-06-09 | Ranbaxy Laboratories Limited | Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050214372A1 (en) * | 2004-03-03 | 2005-09-29 | Simona Di Capua | Stable pharmaceutical composition comprising an acid labile drug |
WO2006002077A2 (en) * | 2004-06-15 | 2006-01-05 | Teva Pharmaceutical Industries Ltd. | Stable pharmaceutical formulations of benzimidazole compounds |
AR051654A1 (es) * | 2004-11-04 | 2007-01-31 | Astrazeneca Ab | Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones |
AR052225A1 (es) * | 2004-11-04 | 2007-03-07 | Astrazeneca Ab | Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones |
US8227476B2 (en) | 2005-08-03 | 2012-07-24 | Sprout Pharmaceuticals, Inc. | Use of flibanserin in the treatment of obesity |
JP2009513604A (ja) | 2005-10-29 | 2009-04-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体 |
CN101389316A (zh) * | 2005-12-28 | 2009-03-18 | 武田药品工业株式会社 | 控制释放固体制剂 |
CN101389317A (zh) * | 2005-12-28 | 2009-03-18 | 武田药品工业株式会社 | 控制释放固体制剂 |
WO2008000760A1 (en) | 2006-06-30 | 2008-01-03 | Boehringer Ingelheim International Gmbh | Flibanserin for the treatment of urinary incontinence and related diseases |
CL2007002214A1 (es) | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
KR20090042967A (ko) | 2006-08-14 | 2009-05-04 | 베링거 인겔하임 인터내셔날 게엠베하 | 플리반세린 제형 및 이의 제조방법 |
AR062321A1 (es) * | 2006-08-25 | 2008-10-29 | Boehringer Ingelheim Int | Sistema de liberacion controlada y metodo para fabricarlo |
AU2008211600B8 (en) | 2007-02-01 | 2014-02-13 | Mars, Incorporated | Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts |
PE20091188A1 (es) | 2007-09-12 | 2009-08-31 | Boehringer Ingelheim Int | Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen |
WO2009113090A2 (en) * | 2008-01-17 | 2009-09-17 | Alkem Laboratories Ltd. | Process for preparing an oral formulation of an acid-sensitive benzimidazole drug |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
CA2686480A1 (en) | 2008-12-15 | 2010-06-15 | Boehringer Ingelheim International Gmbh | New salts |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
EP0723436B1 (de) * | 1994-07-08 | 2001-09-26 | AstraZeneca AB | Aus mehreren einzeleinheiten zusammengesetzte dosierungsform in tablettenform (i) |
-
1997
- 1997-11-05 AU AU51798/98A patent/AU5179898A/en not_active Abandoned
- 1997-11-05 ZA ZA979937A patent/ZA979937B/xx unknown
- 1997-11-05 DE DE69729950T patent/DE69729950T2/de not_active Expired - Fee Related
- 1997-11-05 AT AT97946676T patent/ATE271379T1/de not_active IP Right Cessation
- 1997-11-05 EP EP97946676A patent/EP0941074B1/de not_active Expired - Lifetime
- 1997-11-05 WO PCT/US1997/020851 patent/WO1998019668A1/en active IP Right Grant
-
1999
- 1999-05-05 NO NO992186A patent/NO992186D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0941074B1 (de) | 2004-07-21 |
ATE271379T1 (de) | 2004-08-15 |
ZA979937B (en) | 1999-05-18 |
EP0941074A1 (de) | 1999-09-15 |
DE69729950D1 (de) | 2004-08-26 |
DE69729950T2 (de) | 2005-07-28 |
AU5179898A (en) | 1998-05-29 |
NO992186L (no) | 1999-05-05 |
WO1998019668A1 (en) | 1998-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO992186D0 (no) | System med forsinket avlevering for syresensitive medikamenter | |
AU1488295A (en) | Pharmaceutical composition | |
DE60021604D1 (de) | Gastroretentive pharmazeutische dosierungsformen mit gesteuerten abgaben | |
NO982302L (no) | Farmas°ytisk sammensetning | |
PT1117386E (pt) | Administracao enterica e colonica utilizando capsulas de hpmc | |
NZ237516A (en) | Device for drug delivery to intestinal tract comprising a core of active ingredient together with osmotically activated expulsion agent and an outer coating containing a hydrophobic material to assist in delaying release | |
MX9500885A (es) | Preparacion farmaceutica para administracion oral. | |
NO20003640L (no) | Ny doseringsform | |
RU99126869A (ru) | Фармацевтический препарат омепразола | |
IT1246382B (it) | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon | |
NZ711298A (en) | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents | |
DK0754452T3 (da) | Farmaceutisk præparat i form af en overtrukket kapsel, der frigives i den nedre del af fordøjelsessystemet | |
US5824341A (en) | Composition providing selective release of an active ingredient | |
MXPA05001243A (es) | Formulacion de lamotrigina de liberacion prolongada y uso de la misma para su preparacion. | |
WO2001024777A1 (en) | Coated solid dosage forms | |
CA2304135C (en) | Medicament formulation with a controlled release of an active agent | |
KR20220113697A (ko) | 알칼리제 및 장용성 코팅층을 포함하는 투여 형태 | |
WO2001078681A1 (fr) | Systeme d'administration de medicament empechant l'interaction pharmacocinetique entre les medicaments et procede correspondant | |
AU2009247712C1 (en) | Compositions and methods for inhibiting gastric acid secretion | |
AU2020330542A1 (en) | Articles and methods for administration of therapeutic agents | |
US20060043207A1 (en) | Apparatus, kit and related methods for administering substances | |
US6074669A (en) | Controlled drug delivery system for diltiazem | |
AU2014239683A1 (en) | Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability | |
WO2004041244A2 (en) | Oral extended release tablets and methods of making and using the same | |
JPH06256166A (ja) | 薬物放出制御製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |